5 results match your criteria: "USA (Arrufat); Pittsburgh Veterinary Specialty and Emergency Center[Affiliation]"
Can Vet J
December 2024
Surgery, Sugar Land Veterinary Specialists, 1515 Lake Pointe Parkway, Sugar Land, Texas 77478, USA (Arrufat); 808 Woodrow Street, Houston, Texas 77006, USA (Arrufat); Pittsburgh Veterinary Specialty and Emergency Center, BluePearl Veterinary Partners - Surgery, 807 Camp Horne Road, Pittsburgh, Pennsylvania 15237, USA (Chisnell).
Background: Bipolar vessel-sealing devices (BVSD) have been used for muscle transection in canine limb amputations; however, a retrospective study of their use, and particularly the short-term complications, has not yet been reported.
Objectives: To describe the use of a BVSD as the main method for muscle transection in canine limb amputations and to report the incidence of short-term incisional complications following these surgeries.
Animals And Procedure: Medical records of dogs undergoing limb amputations using a BVSD from January 2017 to December 2018 were reviewed for demographics, preoperative findings, intraoperative complications, and short-term outcomes.
Clin Epidemiol
June 2023
Catalan Health Service, Barcelona, Spain.
Purpose: To assess the contribution of age and comorbidity to the risk of critical illness in hospitalized COVID-19 patients using increasingly exhaustive tools for measuring comorbidity burden.
Patients And Methods: We assessed the effect of age and comorbidity burden in a retrospective, multicenter cohort of patients hospitalized due to COVID-19 in Catalonia (North-East Spain) between March 1, 2020, and January 31, 2022. Vaccinated individuals and those admitted within the first of the six COVID-19 epidemic waves were excluded from the primary analysis but were included in secondary analyses.
Risk Manag Healthc Policy
November 2021
Digitalization for the Sustainability of the Healthcare System (DS3), Sistema de Salut de Catalunya, Barcelona, Spain.
Background: Comorbidity burden has been identified as a relevant predictor of critical illness in patients hospitalized with coronavirus disease 2019 (COVID-19). However, comorbidity burden is often represented by a simple count of few conditions that may not fully capture patients' complexity.
Purpose: To evaluate the performance of a comprehensive index of the comorbidity burden (Queralt DxS), which includes all chronic conditions present on admission, as an adjustment variable in models for predicting critical illness in hospitalized COVID-19 patients and compare it with two broadly used measures of comorbidity.
Alzheimers Dement
June 2022
Eli Lilly and Company, Firenze, Italy.
Risk Manag Healthc Policy
March 2020
Vall d'Hebron Hospital, Barcelona, Spain.
Background: Accurate risk adjustment is crucial for healthcare management and benchmarking.
Purpose: We aimed to compare the performance of classic comorbidity functions (Charlson's and Elixhauser's), of the All Patients Refined Diagnosis Related Groups (APR-DRG), and of the Queralt Indices, a family of novel, comprehensive comorbidity indices for the prediction of key clinical outcomes in hospitalized patients.
Material And Methods: We conducted an observational, retrospective cohort study using administrative healthcare data from 156,459 hospital discharges in Catalonia (Spain) during 2018.